Skip to content

Effect of Planned Visual Training on Heart Failure Patients

Does Planned Visual Training Affect the Attitudes, Beliefs and Symptoms of Individuals with Heart Failure Towards Their Disease?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06807671
Enrollment
110
Registered
2025-02-04
Start date
2021-09-01
Completion date
2022-03-30
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, health belief model, patient training, nursing

Brief summary

This study was conducted to evaluate the effects of planned visual education based on the Health Belief Model on the attitudes, beliefs, and symptoms of heart failure patients towards their disease. Planned visual education based on the Health Belief Model has positive effects on the attitudes, beliefs, and symptoms of heart failure patients towards their disease.

Detailed description

This study, which evaluated the effects of planned visual education based on the Health Belief Model on the attitudes, beliefs, and symptoms of patients with heart failure towards their disease, was conducted with 110 heart failure patients. The study was planned as a randomized controlled experimental study conducted on two groups as intervention (n = 55) and control group (n = 55). The study was conducted between September 2021 and March 2022 at Manisa Celal Bayar University (MCBU) Hafsa Sultan Hospital Cardiology Polyclinic. Simple randomization method was used in assigning the sample group to the experimental and control groups. Data were collected using the Patient Identification Form, the Health Belief Model Scale - Heart Failure and Memorial Symptom Assessment Scale - Heart Failure.

Interventions

OTHERExperimental Group

Patients in the intervention group received HBM based training for a period of 6 months. During the training, one-on-one interviews were provided with each patient. Patients were shown a power point presentation, a brochure, and 3 training videos. Any questions patients had were answered one-on-one.

Sponsors

Celal Bayar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

Participants in the study do not know whether they are in the experimental or control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 18 and 65, * Those with no communication problems, * Those diagnosed with NYHA I-II heart failure, * Those without cognitive impairment, * Those who can understand and speak Turkish, * Those who agree to participate in the study.

Exclusion criteria

* Patients who do not agree to participate in the study, * Patients who want to leave the study, * Patients with NYHA III-IV heart failure diagnosis, * Patients diagnosed with cancer, * Patients with diabetic foot or amputation.

Design outcomes

Primary

MeasureTime frameDescription
Data collection toolPre-testIn order to monitor the effectiveness of the intervention in the study, a 6-month follow-up was conducted and data were collected from the intervention group 3 times (before the intervention, at 3 months and at 6 months) and from the control group twice (at the first interview and at 6 months) through data collection forms. HBM-based education program was applied to the intervention group as an intervention. Data collection tools were Patient Information Form, Memorial Symptom Assessment Scale - Heart Failure (MSAS-HF) and Health Belief Model Scale in Heart Failure (HBM-HF). Patient Information Form: A total of 15 questions are included, including sociodemographic information (such as age, gender, marital status, education status, employment status, occupation and income status) and additional information regarding HF/HF treatment (perceived health status, compliance with diet, exercise, treatment compliance, regular doctor visits, etc.) of the participants.

Secondary

MeasureTime frameDescription
Data collection tool3 monthIn the study, 3-month data were collected from the intervention group using the same measurement tools. MSAS-HF: The scale is used to evaluate the symptoms experienced by patients with HF. It consists of three sub-dimensions in total (physical symptoms, psychological symptoms, and HF symptoms). For the symptoms encountered, it is expected to rate the frequency and severity of the symptom with a four-point Likert-type assessment, and the discomfort with a five-point Likert-type assessment. In the calculation, symptom load is first calculated for each symptom. The load of the unseen symptom is evaluated as zero. The Cronbach alpha values of the scale were reported as 0.53 for physical symptoms, 0.63 for psychological symptoms, and 0.55 for HF symptoms.

Other

MeasureTime frameDescription
Data collection tool6-months / Post-testIn the 6th month of the study, after the educational intervention was completed, data were collected again from the intervention and control groups through data collection forms. HBM-HF: The scale was developed to assess the attitudes and beliefs of HF patients towards their disease. The scale consists of 24 items and five sub-dimensions (perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy) and is a five-point Likert-type scale. The items of the perceived barrier sub-dimension in the scale are reverse coded. The scale does not have a total score and each sub-dimension is calculated independently. Higher scores indicate higher perception of susceptibility, perceived severity, perceived benefits, and good self-efficacy, while lower scores indicate stronger perception of barriers. The Cronbach's alpha coefficients of the sub-dimensions are 0.91, 0.86, 0.88, 0.75, and 0.84, respectively.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026